NOOTROPIC
Selank
Certificate of Analysis / Lot SPSLNK001
99.86% pure
Independent testing & batch documentation
Certificates of Analysis.
Review batch-specific third-party laboratory results, including HPLC chromatograms, mass spectrometry identity confirmation, and purity data for our research compounds.
Third-party tested
Independent analytical reports for every listed batch.
Batch specific
Match your vial label to its corresponding batch record.
Purity documented
Each report provides clear purity and identity results.
Easy access
Open laboratory documentation the moment you need it.
Latest certificates of analysis
Select a compound to view its available batch documentation.
COENZYME
NAD+
Certificate of Analysis / Lot SPNAD001
99.03% pure
IMMUNE
KPV
Certificate of Analysis / Lot SPKPV001
98.42% pure
GHRH ANALOG
Tesamorelin
Certificate of Analysis / Lot SPTESA001
99.32% pure
Documentation
Understanding your COA
A Certificate of Analysis provides transparent, batch-level documentation for each research compound. Use the product and lot number printed on your vial to locate the corresponding report and review its analytical results.
- HPLC purity analysis: review the chromatogram and reported purity for the tested lot.
- Mass spectrometry: confirm the reported molecular mass and compound identity.
- Lot verification: match the lot number on your product label before referencing a report.
Lot SPSLNK001 · Selank
HPLC-UV result
Purity target>98.0%
Reported purity99.86%
Fill accuracy107.2%
Tested Aug 1, 2026 · Testides Analytical Laboratory
Laboratory results
Batch documentation library
9 lots currently hold a third-party certificate. The remainder are listed as awaiting their report.
| Product | Lot | Purity | Date tested | Result | Report |
|---|---|---|---|---|---|
|
Selank
NOOTROPIC
|
SPSLNK001 | 99.86% | Aug 1, 2026 | Pass | |
|
NAD+
COENZYME
|
SPNAD001 | 99.03% | Jul 31, 2026 | Pass | |
|
KPV
IMMUNE
|
SPKPV001 | 98.42% | Jul 30, 2026 | Pass | |
|
Tesamorelin
GHRH ANALOG
|
SPTESA001 | 99.32% | Jul 9, 2026 | Pass | |
|
Dermal Repair Blend
BLEND
|
SPGLOW001 | 99.42% | Jul 7, 2026 | Pass | |
|
GHK-Cu
SKIN & TISSUE
|
SPGHK001 | 99.73% | Jul 7, 2026 | Pass | |
|
BPC-157
RECOVERY
|
SPBPC001 | 98.15% | Jul 2, 2026 | Pass | |
|
Retatrutide
TRIPLE AGONIST
|
SPRETA001 | 99.85% | Jul 2, 2026 | Pass | |
|
Tirzepatide
GLP-1/GIP
|
SPTIRZ001 | 99.72% | Jul 2, 2026 | Pass | |
|
5-Amino-1MQ
NNMT INHIBITOR
|
— | — | — | In testing | Awaiting report |
|
Bacteriostatic Water
SUPPLIES
|
— | — | — | Not assayed | N/A |
|
Cagrilintide
AMYLIN ANALOG
|
— | — | — | In testing | Awaiting report |
|
CJC-1295 (DAC)
GH SECRETAGOGUE
|
— | — | — | In testing | Awaiting report |
|
CJC-1295 (no DAC)
GH SECRETAGOGUE
|
— | — | — | In testing | Awaiting report |
|
CJC-1295 & Ipamorelin
BLEND
|
— | — | — | In testing | Awaiting report |
|
Epitalon
LONGEVITY
|
— | — | — | In testing | Awaiting report |
|
FOXO4-DRI
SENOLYTIC
|
— | — | — | In testing | Awaiting report |
|
HCG
GLYCOPROTEIN
|
— | — | — | In testing | Awaiting report |
|
Immune Repair Blend
BLEND
|
— | — | — | In testing | Awaiting report |
|
Ipamorelin
GH SECRETAGOGUE
|
— | — | — | In testing | Awaiting report |
|
Melanotan-2
MELANOCORTIN
|
— | — | — | In testing | Awaiting report |
|
MOTS-c
MITOCHONDRIAL
|
— | — | — | In testing | Awaiting report |
|
PT-141
MELANOCORTIN
|
— | — | — | In testing | Awaiting report |
|
Recovery Blend
BLEND
|
— | — | — | In testing | Awaiting report |
|
Semaglutide
GLP-1
|
— | — | — | In testing | Awaiting report |
|
Semax
NOOTROPIC
|
— | — | — | In testing | Awaiting report |
|
SS-31
MITOCHONDRIAL
|
— | — | — | In testing | Awaiting report |
|
TB-500
RECOVERY
|
— | — | — | In testing | Awaiting report |
|
Thymosin Alpha-1
IMMUNE
|
— | — | — | In testing | Awaiting report |
Preview build
Every figure in this table is transcribed from the original third-party certificate for that lot — no sample data. Those certificates are issued to the source vendor, not to WellnessVials, and are shown unedited for design approval only; they will be reissued under the WellnessVials account before launch. Compounds with no certificate yet are listed as awaiting their report rather than given a placeholder figure. Every lot tested. Every lot documented.
Browse the catalog and review purity data before you order.